[HTML][HTML] The development of COVID-19 treatment

Y Yuan, B Jiao, L Qu, D Yang, R Liu - Frontiers in immunology, 2023 - frontiersin.org
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …

[HTML][HTML] Diabetes and the COVID-19 pandemic

K Khunti, J Valabhji, S Misra - Diabetologia, 2023 - Springer
Almost immediately after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) virus emerged, it was evident that people with chronic diseases, including diabetes, were …

[HTML][HTML] From archipelago to pandemic battleground: unveiling Indonesia's COVID-19 crisis

BN Harapan, T Harapan, L Theodora… - Journal of Epidemiology …, 2023 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented
challenges to countries worldwide, including Indonesia. With its unique archipelagic …

[HTML][HTML] Pharmacological potential of Withania somnifera (L.) Dunal and Tinospora cordifolia (Willd.) Miers on the experimental models of COVID-19, T cell …

ZA Rizvi, P Babele, U Madan, S Sadhu… - Frontiers in …, 2023 - frontiersin.org
Cytokine release syndrome (CRS) due to severe acute respiratory coronavirus-2 (SARS-
CoV-2) infection leads to life-threatening pneumonia which has been associated with …

Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach

FA Ambrosio, G Costa, I Romeo… - Journal of Chemical …, 2023 - ACS Publications
The SARS-CoV-2 main protease (Mpro) is a crucial enzyme for viral replication and has
been considered an attractive drug target for the treatment of COVID-19. In this study, virtual …

An Educational Mobile Health Application for Pulmonary Rehabilitation in Patients with Mild to Moderate COVID-19 Pneumonia

HT Çaliş, İ Cüce, E Polat, S Hopcan… - … of Research on …, 2023 - igi-global.com
There is an urgent need for individuals with mild to moderate COVID-19 pneumonia to learn
and apply the recommended interventions for pulmonary rehabilitation. In the health …

[HTML][HTML] Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV

A Ricci, GN Roviello - Life, 2023 - mdpi.com
A complex network of processes inside the human immune system provides resistance
against a wide range of pathologies. These defenses form an innate and adaptive immunity …

[HTML][HTML] Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapy

R Batool, M Soler, F Colavita, L Fabeni… - Biosensors and …, 2023 - Elsevier
Monoclonal antibody (mAb) therapy is one of the most promising immunotherapies that have
shown the potential to prevent or neutralize the effects of COVID-19 in patients at very early …

[HTML][HTML] Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State

A Libra, N Ciancio, G Sambataro, E Sciacca… - Viruses, 2023 - mdpi.com
Remdesivir is one of the most attractive options for patients with hypoxemic respiratory
failure due to coronavirus disease 2019 (COVID-19). The aim of our study was to evaluate …

[HTML][HTML] The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection

LW Lu, Y Gao, SY Quek, M Foster, CT Eason… - Biomedicine & …, 2022 - Elsevier
Abstract The Coronavirus Disease-2019 (COVID-19) pandemic urges researching
possibilities for prevention and management of the effects of the virus. Carotenoids are …